P Prime Medicine, Inc.: insider trades · United States · SEC (Form 4) Discover the full management transaction log of Prime Medicine, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €640.3m. The latest transaction was reported on 5 August 2025 (Acquisition). Among the most active insiders: GV 2019 GP, L.L.C.. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 5 August 2025
All Executives36 Thresholds0 Prospectus0 Other0
Declarations 36 total
▲ 10% Owner · Executives · 1 Aug 2025
1,500,000 shares @ US$3.30 100.0% of flow Common Stock SEC:0001415889-25-021025:0
Ideal exit: 28 Apr 2026 (T+270) ▲ Chief Executive Officer · Executives · 21 May 2025
125,000 shares @ US$1.1772 100.0% of flow Common Stock SEC:0001894562-25-000026:0
Ideal exit: 15 Feb 2026 (T+270) ▲ Chief Business Officer · Executives · 20 May 2025
20,000 shares @ US$1.1895 100.0% of flow Common Stock SEC:0001894562-25-000030:0
Ideal exit: 14 Feb 2026 (T+270) ▲ Chief Technical Officer · Executives · 21 May 2025
100,000 shares @ US$1.13 100.0% of flow Common Stock SEC:0001894562-25-000028:0
Ideal exit: 15 Feb 2026 (T+270) ● See Remarks · Executives · 8 Oct 2024
226,925 shares 0Common Stock SEC:0001894562-24-000043:0
● See Remarks · Executives · 5 Jun 2024
250,000 shares 0Common Stock SEC:0001894562-24-000026:0
3,200,000 shares @ US$6.25 100.0% of flow Common Stock SEC:0001062993-24-003739:0
Ideal exit: 11 Nov 2024 (T+270) ▲ Director · Executives · 15 Feb 2024
3,200,000 shares @ US$6.25 100.0% of flow Common Stock SEC:0001062993-24-003740:0
Ideal exit: 11 Nov 2024 (T+270) 3,200,000 shares @ US$6.25 100.0% of flow Common Stock SEC:0001062993-24-003738:0
Ideal exit: 11 Nov 2024 (T+270) ● See Remarks · Executives · 11 Nov 2023
7,500 shares 0Common Stock SEC:0001894562-23-000034:0
1,000,000 shares 0Common Stock SEC:0001894562-23-000032:0
1,000,000 shares 0Common Stock SEC:0001894562-23-000030:0
37,405 shares 0Common Stock SEC:0001209191-23-039122:0
66,659 shares 0Common Stock SEC:0001209191-23-038363:0
28,100 shares 0Common Stock SEC:0001209191-23-037334:0
15,672 shares 0Common Stock SEC:0001209191-23-036666:0
▼ 10% Owner · Executives · 9 Jun 2023
15,672 shares @ US$14.4834 5.4% of flow Common Stock SEC:0001209191-23-036666:1
● 10% Owner · Executives · 12 Jun 2023
16,031 shares 0Common Stock SEC:0001209191-23-036666:2
▼ 10% Owner · Executives · 12 Jun 2023
16,031 shares @ US$14.9804 5.7% of flow Common Stock SEC:0001209191-23-036666:3
15,000 shares 0Common Stock SEC:0001209191-23-035849:0
22,434 shares 0Common Stock SEC:0001209191-23-035068:0
16,633 shares 0Common Stock SEC:0001209191-23-033697:0
12,602 shares 0Common Stock SEC:0001209191-23-033107:0
7,900 shares 0Common Stock SEC:0001209191-23-032529:0
87,922 shares 0Common Stock SEC:0001209191-23-031916:0
25 of 36 declarations
Load more (11 remaining)